Catching up in the pharmaceutical sector: Lessons from case studies of India and Brazil

Economic Development as a Learning Process: Variation Across Sectoral Systems

Volumn , Issue , 2012, Pages 157-193

  Ramani, Shyama V ^a   Guennif, Samira ^b  

^a ECOLE POLYTECHNIQUE   (France)

^b UNIVERSITÉ PARIS 13   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882040026     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4337/9780857937896.00009     Document Type: Chapter

References (54)

1. Abramovitz, M. (1986), 'Catching-up, forging and falling behind', The Journal of Economic History, 46(2), 385-406.
2. Achilladelis, B. and N. Antonakis (2001), 'The dynamics of technological innovation: the case of the pharmaceutical industry', Research Policy, 30(4), 535-88.
3. Andréa-Loyola, M. (2009), 'SIDA, sante publique et politique du medicament au Brésil: autonomie ou dependence', Sciences Sociales et Santé, 27(3), 47-74.
4. Athreye, S., D. Kale and S.V. Ramani (2008), 'Experimentation with strategy and the evolution of dynamic capability in the Indian pharmaceutical sector', Industrial and Corporate Change, 18(4), 729-59.
5. Basheer, S. (2008), 'Ranbaxy-Daiichi merger: an emerging ardhnarishwar model?', DNA (India), available at: http://sify.com/finance/fullstory.php?id=14712790.
6. Bermudez, J.A.Z. and M.A. Oliveira (2004), Intellectual Property in the Context of the WTO TRIPS Agreement, Rio de Janeiro: WHO/PAHO Collaborating Center for Pharmaceutical Policies, National School of Public Health, Sergio Arouca and Oswaldo Cruz Foundation.
7. Bermudez, J.A.Z., M.A. Oliveira and E. Andrade de Oliveira (2004), 'Expand access to essential medicines in Brazil: recent regulation and public policies', in J.A.Z. Bermudez and M.A. Oliveira (eds), Intellectual Property in the Context of the WTO TRIPS Agreement, Rio de Janeiro: WHO/PAHO Collaborating Center for Pharmaceutical Policies, National School of Public Health, Sergio Arouca and Oswaldo Cruz Foundation, pp. 129-51.
8. Burton, H.J. (1998), 'A reconsideration of import substitution', Journal of Economic Literature, XXXVI, 903-36.
9. Cassier, M. and M. Correa (2008), 'Scaling up and reverse-engineering: acquisition of industrial knowledge by copying drugs in Brazil', in B. Coriat (ed.), The Political Economy of HIV/AIDS in Developing Countries: TRIPS, Public Health Systems and Free Access, Cheltenham, UK and Northampton, MA, USA: Edward Elgar, pp. 130-49.
10. Chaturvedi, S. (2007), 'Exploring interlinkages between national and sectoral innovation systems for rapid technological catch-up: case of Indian biopharmaceutical industry', Technology Analysis and Strategic Management, 19(5), 643-59.
11. Chaudhuri, S. (2005), The WTO and India's Pharmaceuticals Industry, New Delhi: Oxford University Press.
12. Chaudhuri, S. (2007), 'Is product patent protection necessary in developing countries for innovation? R&D by Indian Pharmaceutical Companies after TRIPS', Calcutta: Indian Institute of Management Calcutta, Working Paper Series: WPS No. 614/September 2007.
13. Cohen, J.C. (2000), 'Public policies in the pharmaceutical sector: a case study of Brazil', Washington, DC: The World Bank, Latin America and the Caribbean Regional Office, Human Development Department, LCSHD Paper Series.
14. De Albuquerque Possas, C. (2008), 'Compulsory licensing in the real world: the case of ARV drugs in Brazil', in B. Coriat (ed.), The Political Economy of HIV/ AIDS in Developing Countries: TRIPS, Public Health Systems and Free Access, Cheltenham, UK and Northampton, MA, USA: Edward Elgar.
15. De Lemos Capanema, L.X. (2006), 'A industria farmaceutica Brasileira e a atuaçao do BNDES', Rio de Janeiro: BNDES Sectorial.
16. Edquist, C. (1997), Systems of Innovation: Technologies, Institutions and Organizations, London: Pinter.
17. Fagerberg, J. and M. Godinho (2004), 'Innovation and catch-up', in J. Fagerberg, D. Mowery and R. Nelson (eds), Handbook of Innovation, Oxford: Oxford University Press, pp. 514-43.
18. Fialho, B., L. Hasenclever and J.M.C. Mello (2004), 'The geography of innovation in the pharmaceutical industry: assessing implications for developing countries', in D. Gibson, M. Heitor and A. Ibarra (eds), Connecting People, Ideas and Resources across Communities, West Lafayette, IN: Purdue University Press.
19. Freeman, C. (1995), 'The national system of innovation in historical perspective', Cambridge Journal of Economics, 19(1), 5-24.
20. Frischtak, C.R. (1989), 'The protection of intellectual property rights and industrial technology development in Brazil', Washington, DC: The World Bank, Industrial and Energy Department, working paper, Industry Series.
21. Gehl-Sampath, P. (2008), India's Pharmaceutical Sector in 2008: Emerging Strategies and Global and Local Implications for Access to Medicines, London: Department for International Development, DFID.
22. Greene, W. (2007), 'The emergence of India's pharmaceutical industry and implications for the US generic drug market', Washington, DC: Office of Economics Working Paper, US International Trade Commission.
23. Guennif, S. (2007), 'Droits de propriete intellectuelle et sante publique dans les pays du sud: l'enjeu des medicaments antisida', Transcontinentales, no. 5, 19-37.
24. Hasenclever, L. and J. Paranhos (2008), 'The development of the pharmaceutical industry in Brazil and India: technological capability and industrial development', mimeo.
25. Kale, D. and S. Little (2007), 'From imitation to innovation: the evolution of R&D capabilities and learning processes in the Indian pharmaceutical industry', Technology Analysis and Strategic Management, 19(5), 589-611.
26. Kaushal, L.M. (2007), 'Drug price control order and recent developments', available at: http://pharmexcil.com/data/uploads/5.DrugsPriceControlOrderandRecentDeve lopments.pdf.
27. Lall, S. (1974a), 'International pharmaceutical industry and less-developed countries', Economic and Political Weekly, 9(47), 1990-96.
28. Lall, S. (1974b), 'The international pharmaceutical industry and less-developed countries, with special reference to India', Oxford Bulletin of Economics and Statistics, 36(3), 143-72.
29. Lundvall, B.-Å. (1992), National Innovation Systems: Towards a Theory of Innovation and Interactive Learning, London: Pinter.
30. Malerba, F. (2002), 'Sectoral systems of innovation and production', Research Policy, 31(2), 247-64.
31. Malerba, F. and L. Orsenigo (2002), 'Innovation and market structure in the dynamics of the pharmaceutical industry and biotechnology: towards a historyfriendly model', Industrial and Corporate Change, 11(4), 667-703.
32. McKelvey, M., L. Orsenigo and F. Pammolli (2004), 'Pharmaceuticals analyzed through the lens of a sectoral innovation system', in F. Malerba (ed.), Sectoral Systems of Innovation: Concepts, Issues and Analyses of Six Major Sectors in Europe, Cambridge: Cambridge University Press, pp. 73-120.
33. Nassif, A. (2007), 'National innovation system and macroeconomic policies: Brazil and India in comparative perspective', paper presented at the United Nations Conference on Trade and Development.
34. Nelson, R. (1993), National Innovation Systems: A Comparative Analysis, Oxford: Oxford University Press.
35. Nelson, R. (2008), 'Economic development from the perspective of evolutionary economic theory', Oxford Development Studies, 36(1), 9-21.
36. Office of Technology Assessment (OTA) (1986), 'Intellectual property rights in an age of electronics information', Washington, DC: US Government Printing Office, p. 228.
37. OPPI (2001, 2004), 'Organisation of Pharmaceutical Producers of India: Pharmaceutical Compendium', Mumbai.
38. Orsi, F., L. Hasenclever, B. Fialho, P. Tigre and B. Coriat (2003), 'Intellectual property rights, anti-AIDS policy and generic drugs: lessons from the Brazilian public health program', in J.P. Moatti, B. Coriat, Y. Souteyrand, T. Barnett, J. Dumoulin and Y.A. Flori (eds), Economics of AIDS and Access to HIV/AIDS Care: Issues and Challenges, Paris: Edition de l'Agence Nationale de Recherches sur le SIDA.
39. Queiroz, S.R.R. (1993), 'Os determinantes da capacitaçao tecnologica no sector quimico-farmaceutico Brasileiro', Ph.D. thesis, Department of Economics, UNICAMP.
40. Queiroz, S.R.R. (1994), 'Un transfert reussi et contrarie par une politique de developpement national: la production pharmaceutique', in C. Durand (ed.), La Coopération Internationale et les transferts de Technologie, Brussels: De Boeck.
41. Ramani, S.V. (2002), 'Who's interested in biotechnology: R&D strategies, knowledge base and market sales of Indian biopharmaceutical firms', Research Policy, 31(3): 381-98.
42. Ramani, S.V. and A. Maria (2005), 'TRIPS and its possible impact on the biotech based segment of the Indian pharmaceutical industry', Economic and Political Weekly, 12-18 February, pp. 675-83.
43. Ramani, S.V. and M. S. Venkataramani (2001), 'Rising to the technological challenge: integration of biotechnology in the Indian pharmaceutical industry', International Journal of Biotechnology, 3(1/2), 95-115.
44. Redwood, H. (1994), New Horizons in India, Suffolk: Oldwicks Press Limited.
45. Robine, A. (2008), 'Transfert et acquisition de la technologie dans les pays émergents: l'exemple bresilien de l'acces aux medicaments contre le sida', Ph.D. thesis, Department of Economics, Université Paris 1 Panthéon-Sorbonne.
46. Rodrigo, A. and J. Sutz (2000), 'Looking at national systems of innovation from the south', Industry & Innovation, 7(1), 55-75.
47. Singh, N. (2008), 'A win win deal', Biospectrum (India), available at: http://biospectrumindia.ciol.com/content/BioBusiness/10807111.asp.
48. Singh, S. (1985), Multinational Corporations and Indian Drug Industry, New Delhi: Criterion Publications.
49. Soete, L. (1985), 'International diffusion of technology, industrial development and technological leapfrogging', World Development, 13(3), 409-22.
50. Srinivasan, S. (2007), 'Battling patent laws: the Glivec case', Economic and Political Weekly, 15 September, pp. 3686-91.
51. Suzigan, W. and J. Furtado (2006), 'Industrial policy and development', CEPAL Review.
52. Sweet, C. (2007), 'Regulating the tigers: the institutional dynamics of Indo-Brazilian trade reflections from the pharmaceutical sector', paper presented at ELSNIT Conference on Institutional Dimensions of Integration and Trade, Barcelona.
53. Tribune des droits humains (2007), 'L'industrie Indienne n'aide pas les Indiens', available at http://www.humanrights-geneva.info/article.php3?id_article=2152.
54. Urias, E. and J. Furtado (2009), 'Institutional changes and their impacts on the Brazilian pharmaceutical industry', paper presented at VII GLOBELICS conference, Dakar, Senegal, 6-8 October, 2009.